NF-kB Mediates Cartilage Degradation induced by Trauma Injury and IL-1

dc.contributor.otherSauer, Brent C.en
dc.contributor.otherChen, Christopher T.en
dc.creatorCarter, Kristenen
dc.creatorKashyap, Meghanaen
dc.date.accessioned2015-06-05T12:30:06Z
dc.date.available2015-06-05T12:30:06Z
dc.date.issued2013-01-22
dc.descriptionThe 51st Annual Medical Student Research Forum at UT Southwestern Medical Center (Tuesday, January 22, 2013, 3-6 p.m., D1.602)en
dc.description.abstractBACKGROUND: IL-1 is one of the major pro-inflammatory cytokines responsible for cartilage degradation. Several studies have shown that IL-1 mediates the upregulation of tissue degradation through the NF-κB and Mitogen-activated protein kinase (MAPK, p38) pathways, but its role in cartilage degradation after blunt trauma injury is not clear. The objective of this study was to determine the roles of NF-κB and p38 in IL-1- induced cell death, proteoglycan (PG) degradation, nitric oxide (NO) production, and related gene upregulation in cartilage after blunt injury. METHODS: Full-thickness cartilage plugs were obtained from mature bovine knees (>18 mo) and pre-cultured in DMEM. The signaling pathways (p38 and NF-kB) were inhibited by pretreatment with 10μM SB202190 for p38 (p38i) and 50μM BAY117085 for NF-κB (IκBi) for 1 hour. Samples in Injury and Injury+IL-1 groups received impact injury with impact energy of 15J/cm2. IL-1 and Injury+IL-1 groups were treated with 1 ng/ml IL-1. Cell viability was assessed using fluorescein diacetate and propidium iodine. The mRNA from cartilage was isolated using Trizol and RNeasy Mini kit (Qiagen), reverse transcribed, and analyzed using qPCR to determine pro-inflammatory cytokine and tissue remodeling genes (IL- 6, MMP-3, TIMP-3). All gene expression was normalized to GAPDH. The medium was analyzed for proteoglycan (PG) release/loss and nitric oxide (NO) production using dimethylmethylene blue (DMMB) and Greiss assays, respectively. RESULTS: Increased cell death was found in the Injury and Injuy+IL-1 groups. Increase of PG loss was found in IL-1, Injury and Injury+IL-1 treated groups (37%, 104% and 126%, respectively). Significant decreases (69-73%) of PG loss were found in all IκBi treated groups, while little or no changes were found in the p38 groups. Results from the qPCR analysis supported the findings. IκBi treatment reduced MMP-3 upregulation induced by IL-1 and Injury, while there was minimal change with the p38 inhibitor. Similarly, NO production was also decreased in the IκBi treated groups. DISCUSSION and CONCLUSION: Our study suggests that the NF-κB signaling pathway plays a greater role than p38 in IL-1 mediated PG loss and NO production in cartilage after trauma injury. Future studies are needed to determine the time-course response and specific NF-κB mediators for downstream regulation, as well as the effects in long-term therapeutic treatment to ameliorate the progress of post traumatic osteoarthritis.en
dc.description.sponsorshipSouthwestern Medical Foundationen
dc.identifier.citationCarter, K., Kashyap, M., Sauer, B. C., & Chen, C. T. (2013, January 22). NF-kB mediates cartilage degradation induced by trauma injury and IL-1. Poster session presented at the 51st Annual Medical Student Research Forum, Dallas, TX. Retrieved from https://hdl.handle.net/2152.5/1605en
dc.identifier.urihttps://hdl.handle.net/2152.5/1605
dc.language.isoenen
dc.relation.ispartofseries51st Annual Medical Student Research Forumen
dc.subjectBasic Research and Disease Modelsen
dc.subject.meshCartilageen
dc.subject.meshInterleukin-1en
dc.subject.meshMitogen-Activated Protein Kinasesen
dc.subject.meshNF-kappa Ben
dc.titleNF-kB Mediates Cartilage Degradation induced by Trauma Injury and IL-1en
dc.typePresentationen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Carter and Kashyap MSRF Trauma-IL1 2013 Poster v4.pdf
Size:
775.45 KB
Format:
Adobe Portable Document Format
Description:
PDF--public access

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
297 B
Format:
Item-specific license agreed upon to submission
Description: